Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility.

Source:http://linkedlifedata.com/resource/pubmed/id/19570853

Download in:

View as

General Info

PMID
19570853